Causes of Death in Long-term Survivors of Head and Neck Cancer
Overview
Authors
Affiliations
Background: Survivors of head and neck squamous cell carcinoma (HNSCC) face excess mortality from multiple causes.
Methods: We used the population-based Surveillance, Epidemiology, and End Results (SEER) cancer registry data to evaluate the causes of death in patients with nonmetastatic HNSCC diagnosed between 1992 and 2005 who survived at least 3 years from diagnosis (long-term survivors). We used competing-risks proportional hazards regression to estimate probabilities of death from causes: HNSCC, second primary malignancy (SPM) excluding HNSCC, cardiovascular disease, and other causes.
Results: We identified 35,958 three-year survivors of HNSCC with a median age at diagnosis of 60 years (range = 18-100 years) and a median follow-up of 7.7 years (range = 3-18 years). There were 13,120 deaths during the study period. Death from any cause at 5 and 10 years was 15.4% (95% confidence interval [CI] = 15.0%-15.8%) and 41.0% (95% CI = 40.4%-41.6%), respectively. There were 3852 HNSCC deaths including both primary and subsequent head and neck tumors. The risk of death from HNSCC was greater in patients with nasopharynx or hypopharynx cancer and in patients with locally advanced disease. SPM was the leading cause of non-HNSCC death, and the most common sites of SPM death were lung (53%), esophagus (10%), and colorectal (5%) cancer.
Conclusions: Many long-term HNSCC survivors die from cancers other than HNSCC and from noncancer causes. Routine follow-up care for HNSCC survivors should expand beyond surveillance for recurrent and new head and neck cancers.
Performance of 8 Smoking Metrics for Modeling Survival in Head and Neck Squamous Cell Carcinoma.
Lam A, Hueniken K, Pienkowski M, Lee J, Dong M, Diergaarde B JAMA Otolaryngol Head Neck Surg. 2025; .
PMID: 39976935 PMC: 11843462. DOI: 10.1001/jamaoto.2024.5392.
Two-color fluorescence-guided surgery for head and neck cancer resections.
Szafran D, Shams N, Montano A, Rizvi S, Alani A, Samkoe K J Biomed Opt. 2024; 30(Suppl 1):S13707.
PMID: 39473456 PMC: 11519810. DOI: 10.1117/1.JBO.30.S1.S13707.
Udholm S, Sannino-Greve N, Klug T Eur Arch Otorhinolaryngol. 2024; 281(11):5955-5959.
PMID: 39042171 PMC: 11512922. DOI: 10.1007/s00405-024-08830-7.
Kovarik P, Cvek J, Patil R, Macdougall C, Kelly C, Jackson M Strahlenther Onkol. 2024; 200(10):882-894.
PMID: 38918259 DOI: 10.1007/s00066-024-02251-5.
Abdul N, Shivakumar G, Sangappa S, Di Blasio M, Crimi S, Cicciu M BMC Oral Health. 2024; 24(1):122.
PMID: 38263027 PMC: 10804575. DOI: 10.1186/s12903-023-03533-7.